How representative is a point-of-care randomized trial? Clinical outcomes of patients excluded from a point-of-care randomized controlled trial evaluating antibiotic duration for Gram-negative bacteraemia: a multicentre prospective observational cohort study
Anne Rossel(University Hospital of Geneva), Angela Huttner(University Hospital of Geneva), Werner C. Albrich(University of St.Gallen), Kimberly P.M. Zandberg(University of Exeter)
Cited by 9
Related Papers
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
|Intensive Care Medicine|2023|293
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
|The Lancet Infectious Diseases|2015|278
Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage
|Clinical Microbiology and Infection|2019|263
Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials
|Journal of Antimicrobial Chemotherapy|2015|262